UPDATED Apr 24, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ZVRA | US$4.56 | -1.7% | -12.0% | US$191.7m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$3.99 | -6.8% | 62.2% | US$218.7m | US$8.50 | PS2.5x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.57 | -8.6% | -39.2% | US$231.7m | US$26.06 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$143.80 | -1.0% | -27.2% | US$18.5b | US$220.00 | PS9.9x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$13.98 | 1.2% | -36.7% | US$2.2b | US$29.75 | PE170.5x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
SONM | US$0.48 | -9.0% | -59.4% | US$20.6m | US$2.00 | PB0.9x | E139.9% | n/a | Tech | ||
FTCI | US$0.45 | 11.2% | -82.4% | US$52.3m | n/a | PB0.9x | E63.1% | n/a | Capital Goods | ||
ARDX | US$6.39 | -2.4% | 37.1% | US$1.5b | US$13.50 | PS11.9x | E59.6% | n/a | Pharmaceuticals & Biotech | ||
FOLD | US$10.71 | 1.5% | -7.4% | US$3.2b | US$18.78 | PS7.9x | E55.2% | n/a | Pharmaceuticals & Biotech | ||
BRDG | US$6.97 | 5.6% | -29.4% | US$801.5m | US$9.75 | PS1.1x | E88.9% | 9.5% | Diversified Financials | ||
OPTN | US$0.97 | -5.1% | -46.2% | US$109.0m | US$3.75 | PS1.5x | E61.6% | n/a | Pharmaceuticals & Biotech | ||
ACAD | US$16.59 | -3.5% | -18.3% | US$2.8b | US$29.09 | PS3.8x | E40.9% | n/a | Pharmaceuticals & Biotech | ||
SMWB | US$7.77 | 1.3% | 35.4% | US$622.7m | US$10.83 | PS2.8x | E104.3% | n/a | Software | ||
WULF | US$2.52 | 28.6% | 58.5% | US$819.1m | US$3.62 | PS11x | E132.9% | n/a | Software | ||
MVST | US$0.45 | -13.6% | -57.2% | US$143.8m | US$4.50 | PB0.3x | E44.4% | n/a | Capital Goods | ||
HHH | US$64.25 | 8.2% | -13.9% | US$3.2b | US$88.25 | PS3.2x | E107.2% | n/a | Real Estate Management and Development | ||
AZ | US$0.47 | 10.6% | -55.7% | US$23.2m | US$18.00 | PS2.1x | E75.4% | n/a | Capital Goods | ||
MLCO | US$6.27 | -2.0% | -51.5% | US$2.7b | US$10.91 | PE-8.4x | E54.9% | 0% | Consumer Services | ||
ZS | US$177.46 | 2.6% | 90.7% | US$26.5b | US$258.52 | PS14x | E41.1% | n/a | Software | ||
AJX | US$3.54 | 2.0% | -44.5% | US$135.4m | US$6.00 | PB0.5x | E146.1% | 11.3% | Diversified Financials | ||
OWLT | US$3.98 | 16.7% | -17.3% | US$36.0m | US$15.00 | PE-1x | E73.7% | n/a | Healthcare | ||
SACH | US$3.20 | 0.6% | -6.7% | US$151.4m | US$4.42 | PE12.5x | E30.2% | 13.8% | Diversified Financials | ||
BIGC | US$5.83 | -0.3% | -24.1% | US$445.4m | US$9.68 | PS1.4x | E67.9% | n/a | Software | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | Pharmaceuticals & Biotech |